(20S)-2-methylene-19-nor-22dimethyl-1alpha,25dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22dimethyl-1a,25-hydroxyvitamin D3

Details for Australian Patent Application No. 2011232633 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Deluca, Hector F.; Flores, Agnieszka; Grzywacz, Pawel; Plum, Lori A.; Clagett-Dame, Margaret

Agent Spruson & Ferguson

Pub. Number AU-A-2011232633

PCT Pub. Number WO2011/119610

Priority 61/316,631 23.03.10 US

Filing date 22 March 2011

Wipo publication date 29 September 2011

International Classifications

C07C 401/00 Irradiation products of cholesterol or its derivatives

A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61P 17/06 Drugs for dermatological disorders

A61P 19/08 Drugs for skeletal disorders

A61P 37/00 Drugs for immunological or allergic disorders

C07F 7/18 Compounds containing elements of the 4th Group of the Periodic System

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/119610 Priority application(s): WO2011/119610

1 November 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Wisconsin Alumni Research Foundation, Application No. 2011232633, under INID (54) correct the title to read (20S)-2-methylene-19-nor-22-dimethyl-1alpha,25dihydroxyvitamin D3 and (20R)-2methylene-19-nor-22dimethyl-1alpha,25-hydroxyvitamin D3

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011232636-A bracket

2011232632-Histidine rich protein-2 diagnostic test for cerebral malaria